140 related articles for article (PubMed ID: 30038266)
21. Sirtuins Affect Cancer Stem Cells via Epigenetic Regulation of Autophagy.
Sipos F; Műzes G
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397988
[TBL] [Abstract][Full Text] [Related]
22. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
Igder S; Zamani M; Fakher S; Siri M; Ashktorab H; Azarpira N; Mokarram P
Dis Markers; 2024; 2024():9943412. PubMed ID: 38380073
[TBL] [Abstract][Full Text] [Related]
23. CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1.
Zhu X; Yu J; Ai F; Wang Y; Lv W; Yu G; Cao X; Lin J
Breast Cancer (Dove Med Press); 2023; 15():967-984. PubMed ID: 38164371
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1.
Semenza GL
Stem Cells Transl Med; 2023 Dec; 12(12):783-790. PubMed ID: 37768037
[TBL] [Abstract][Full Text] [Related]
25. Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.
Lučić I; Kurtović M; Mlinarić M; Piteša N; Čipak Gašparović A; Sabol M; Milković L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445860
[TBL] [Abstract][Full Text] [Related]
26. KLF4 transcription factor in tumorigenesis.
He Z; He J; Xie K
Cell Death Discov; 2023 Apr; 9(1):118. PubMed ID: 37031197
[TBL] [Abstract][Full Text] [Related]
27. The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer.
Chiang YF; Huang KC; Chen HY; Huang TC; Ali M; Chang HY; Shieh TM; Shih YH; Wang KL; Huang YJ; Chung CP; Hsia SM
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830834
[TBL] [Abstract][Full Text] [Related]
28. New insights into KLFs and SOXs in cancer pathogenesis, stemness, and therapy.
Zeng L; Zhu Y; Moreno CS; Wan Y
Semin Cancer Biol; 2023 May; 90():29-44. PubMed ID: 36806560
[TBL] [Abstract][Full Text] [Related]
29. Narrow Leafed Lupin (
Escudero-Feliu J; García-Costela M; Moreno-SanJuan S; Puentes-Pardo JD; Arrabal SR; González-Novoa P; Núñez MI; Carazo Á; Jimenez-Lopez JC; León J
Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771230
[TBL] [Abstract][Full Text] [Related]
30. NAD
Jiang Y; Luo Z; Gong Y; Fu Y; Luo Y
Oncogene; 2023 Mar; 42(11):808-824. PubMed ID: 36690678
[TBL] [Abstract][Full Text] [Related]
31. PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6.
Zhong L; Tan W; Yang Q; Zou Z; Zhou R; Huang Y; Qiu Z; Zheng K; Huang Z
J Gastrointest Oncol; 2022 Dec; 13(6):2989-3008. PubMed ID: 36636075
[TBL] [Abstract][Full Text] [Related]
32. Targeting Breast Cancer Stem Cells.
Zhang L; Chen W; Liu S; Chen C
Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
[TBL] [Abstract][Full Text] [Related]
33. The sirtuin family in health and disease.
Wu QJ; Zhang TN; Chen HH; Yu XF; Lv JL; Liu YY; Liu YS; Zheng G; Zhao JQ; Wei YF; Guo JY; Liu FH; Chang Q; Zhang YX; Liu CG; Zhao YH
Signal Transduct Target Ther; 2022 Dec; 7(1):402. PubMed ID: 36581622
[TBL] [Abstract][Full Text] [Related]
34. Stemness of Normal and Cancer Cells: The Influence of Methionine Needs and SIRT1/PGC-1α/PPAR-α Players.
Siblini Y; Namour F; Oussalah A; Guéant JL; Chéry C
Cells; 2022 Nov; 11(22):. PubMed ID: 36429035
[TBL] [Abstract][Full Text] [Related]
35. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors.
Wei Y; Li Y; Chen Y; Liu P; Huang S; Zhang Y; Sun Y; Wu Z; Hu M; Wu Q; Wu H; Liu F; She T; Ning Z
Front Oncol; 2022; 12():1026278. PubMed ID: 36387165
[TBL] [Abstract][Full Text] [Related]
36. The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer.
Onyiba CI; Scarlett CJ; Weidenhofer J
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291902
[TBL] [Abstract][Full Text] [Related]
37. The prognostic implications of SIRTs expression in breast cancer: a systematic review and meta-analysis.
Zhang H; Ma C; Peng M; Lv X; Xie X; Huang R
Discov Oncol; 2022 Aug; 13(1):69. PubMed ID: 35927590
[TBL] [Abstract][Full Text] [Related]
38. Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions.
Shen W; He J; Hou T; Si J; Chen S
Aging Dis; 2022 Jul; 13(4):1063-1091. PubMed ID: 35855334
[TBL] [Abstract][Full Text] [Related]
39. Sirtuins and Hypoxia in EMT Control.
Aventaggiato M; Barreca F; Sansone L; Pellegrini L; Russo MA; Cordani M; Tafani M
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745656
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities.
Huang Z; Zhang Z; Zhou C; Liu L; Huang C
MedComm (2020); 2022 Jun; 3(2):e144. PubMed ID: 35601657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
